Checchi Capital Advisers LLC cut its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 11.6% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 7,066 shares of the company’s stock after selling 926 shares during the period. Checchi Capital Advisers LLC’s holdings in Colgate-Palmolive were worth $524,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the stock. State of Wisconsin Investment Board lifted its position in Colgate-Palmolive by 37.0% during the 2nd quarter. State of Wisconsin Investment Board now owns 1,057,643 shares of the company’s stock worth $78,403,000 after acquiring an additional 285,580 shares in the last quarter. WASHINGTON TRUST Co lifted its position in Colgate-Palmolive by 36.6% during the 2nd quarter. WASHINGTON TRUST Co now owns 16,126 shares of the company’s stock worth $1,195,000 after acquiring an additional 4,323 shares in the last quarter. Dupont Capital Management Corp lifted its position in Colgate-Palmolive by 69.6% during the 2nd quarter. Dupont Capital Management Corp now owns 134,788 shares of the company’s stock worth $9,992,000 after acquiring an additional 55,327 shares in the last quarter. Savant Capital LLC lifted its position in Colgate-Palmolive by 1.9% during the 2nd quarter. Savant Capital LLC now owns 10,725 shares of the company’s stock worth $795,000 after acquiring an additional 199 shares in the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in Colgate-Palmolive by 19.0% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 575,613 shares of the company’s stock worth $42,670,000 after acquiring an additional 92,016 shares in the last quarter. 73.09% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Colgate-Palmolive Company (NYSE CL) opened at 75.75 on Tuesday. The stock has a 50 day moving average price of $72.45 and a 200-day moving average price of $73.19. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The company has a market capitalization of $66.72 billion, a P/E ratio of 28.15 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter last year, the company earned $0.70 EPS. The company’s quarterly revenue was down .5% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be given a $0.40 dividend. The ex-dividend date is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total value of $273,867.85. Following the completion of the sale, the insider now owns 53,173 shares in the company, valued at approximately $3,799,210.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total value of $999,040.00. Following the completion of the sale, the senior vice president now owns 88,598 shares of the company’s stock, valued at approximately $6,322,353.28. The disclosure for this sale can be found here. Insiders sold a total of 214,136 shares of company stock valued at $15,416,385 in the last quarter. Corporate insiders own 1.02% of the company’s stock.

Several equities analysts recently commented on CL shares. BidaskClub lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research report on Friday, June 30th. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a research report on Tuesday, July 4th. Jefferies Group LLC boosted their price target on Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a research report on Thursday, July 6th. Finally, Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and five have issued a buy rating to the company’s stock. Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $76.85.

ILLEGAL ACTIVITY NOTICE: “Checchi Capital Advisers LLC Sells 926 Shares of Colgate-Palmolive Company (CL)” was posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international trademark and copyright law. The original version of this piece of content can be read at https://www.watchlistnews.com/checchi-capital-advisers-llc-sells-926-shares-of-colgate-palmolive-company-cl/1635652.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.